All In Biotech

Drug Trial Radar · NCT07463183

A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)

A Phase 2a Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of MK-8690 in Adult Participants With Moderately to Severely Active Ulcerative Colitis

Last checked: Nov 19, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 100 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

100

Planned (sponsor's estimate)

Start

Mar 24, 2026

Primary completion

Oct 28, 2027

Study completion Dec 21, 2028

Sponsor

Lead sponsor
Merck Sharp & Dohme LLCMerck & Co. (MRK)
Sponsor type
Industry
First posted
Mar 11, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this protocol is to evaluate the efficacy of MK-8690 in participants with moderately to severely active ulcerative colitis. The primary hypothesis is that MK-8690 is superior to placebo with respect to the proportion of participants achieving clinical remission per Modified Mayo Score at Week 12.

Conditions

  • Colitis Ulcerative
  • Ulcerative Colitis

Interventions

  • MK-8690Drug

    Solution for subcutaneous injection

  • PlaceboOther

    Solution for subcutaneous injection

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants Achieving Clinical Remission Per Modified Mayo Score (MMS) at Week 12Time frame: Week 12

Locations

43 sites in 12 countries. Site status is shown where the registry gives one.

  • Clinnova Research ( Site 1042)

    Anaheim, California · Recruiting

  • Southern California Research Center ( Site 1044)

    Coronado, California · Recruiting

  • Peak Gastroenterology Associates ( Site 1052)

    Colorado Springs, Colorado · Recruiting

  • South Denver Gastroenterology, PC ( Site 1068)

    Englewood, Colorado · Recruiting

  • Nature Coast Clinical Research ( Site 1045)

    Inverness, Florida · Recruiting

  • Research Associates of South Florida - Miami - Southwest 8th Street ( Site 1072)

    Miami, Florida · Recruiting

  • AdventHealth Orlando ( Site 1074)

    Orlando, Florida · Recruiting

  • Gastroenterology Associates of Central Georgia ( Site 1060)

    Macon, Georgia · Recruiting

  • University of Kansas Medical Center ( Site 1077)

    Kansas City, Kansas · Recruiting

  • Tulane University School of Medicine-Gastroenterology and Hepatology ( Site 1073)

    New Orleans, Louisiana · Recruiting

  • BVL Research - Kansas ( Site 1054)

    Liberty, Missouri · Recruiting

  • Prairie Institute of Liver and Luminal Advanced Research ( Site 1008)

    Lethbridge, Alberta, Canada · Recruiting

  • Toronto Western Hospital ( Site 1006)

    Toronto, Ontario, Canada · Recruiting

  • Centre Hospitalier de l Universite de Montreal - CHUM ( Site 1001)

    Montreal, Quebec, Canada · Recruiting

  • Hospital Clinico Regional Dr. Guillermo Grant Benavente ( Site 1129)

    Concepción, Biobio, Chile · Recruiting

  • Clinica Alemana de Santiago ( Site 1124)

    Santiago, Region M. de Santiago, Chile · Recruiting

  • Clínica MEDS La Dehesa ( Site 1123)

    Santiago, Region M. de Santiago, Chile · Recruiting

  • Servicios de Salud IPS Suramericana S.A.S. - IPS Sura Industriales Medellín ( Site 1163)

    Medellín, Antioquia, Colombia · Recruiting

  • Clinica de la Costa S.A.S. ( Site 1161)

    Barranquilla, Atlántico, Colombia · Recruiting

  • Fundacion Santa Fe de Bogota ( Site 1165)

    Bogota, Cundinamarca, Colombia · Recruiting

  • Fundación Valle del Lili ( Site 1162)

    Cali, Valle del Cauca Department, Colombia · Recruiting

  • Centre Hospitalier Dr Schaffner ( Site 1288)

    Lens, Pas-de-Calais, France · Recruiting

  • Clinique Jules Verne ( Site 1284)

    Nantes, Pays de la Loire Region, France · Recruiting

  • Universitätsklinikum Brandenburg an der Havel ( Site 1323)

    Brandenburg, Germany · Recruiting

  • Universitaetsklinikum Ulm. ( Site 1324)

    Ulm, Baden-Wurttemberg, Germany · Recruiting

  • Evangelismos General Hospital of Athens ( Site 1362)

    Athens, Attica, Greece · Recruiting

  • THORACIC GENERAL HOSPITAL OF ATHENS "I SOTIRIA" ( Site 1361)

    Athens, Attica, Greece · Recruiting

  • IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico di Sant'Orsola ( Site 1404)

    Bologna, Emilia-Romagna, Italy · Recruiting

  • Istituto Clinico Humanitas-IBD center ( Site 1401)

    Rozzano, Milano, Italy · Recruiting

  • Radboudumc ( Site 1650)

    Nijmegen, Gelderland, Netherlands · Recruiting

  • Amsterdam UMC, locatie VUmc ( Site 1651)

    Amsterdam, North Holland, Netherlands · Recruiting

  • Promed P. Lach R. Glowacki s.j. Centrum Medyczne Promed ( Site 1447)

    Krakow, Lesser Poland Voivodeship, Poland · Recruiting

  • Melita Medical Sp Zoo ( Site 1442)

    Wroclaw, Lower Silesian Voivodeship, Poland · Recruiting

  • EB Group Sp. Z o.o. Centrum Zdrowia MDM ( Site 1449)

    Warsaw, Masovian Voivodeship, Poland · Recruiting

  • Medical Network Spółka z o.o. WIP Warsaw IBD Point Profesor Kierkuś ( Site 1448)

    Warsaw, Masovian Voivodeship, Poland · Recruiting

  • Twoja Przychodnia - Szczeciskie Centrum Medyczne ( Site 1450)

    Szczecin, West Pomeranian Voivodeship, Poland · Recruiting

  • Kangbuk Samsung Hospital ( Site 1601)

    Seoul, South Korea · Recruiting

  • Wonju Severance Christian Hospital ( Site 1602)

    Wŏnju, Kang-won-do, South Korea · Recruiting

  • Korea University Ansan Hospital ( Site 1603)

    Ansan-si, Kyonggi-do, South Korea · Recruiting

  • Addenbrooke's Hospital ( Site 1525)

    Cambridge, Cambridgeshire, United Kingdom · Recruiting

Showing 40 of 43 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.